Alamar Biosciences, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $26,035 | $13,091 |
Gross Profit | 14,457 | 6,389 |
EBITDA | -19,471 | |
EBIT | -20,638 | |
Net Income | -21,325 | -7,659 |
Net Change In Cash | 26,035 | 13,091 |
Free Cash Flow | -20,947 | -14,050 |
Cash | 64,586 | |
Basic Shares | 69,311 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $74,211 | $25,142 |
Gross Profit | 41,705 | 8,607 |
EBITDA | -24,889 | |
EBIT | -28,753 | |
Net Income | -29,819 | -47,073 |
Net Change In Cash | 74,211 | 25,142 |
Free Cash Flow | -59,992 | -58,602 |
Cash | 30,002 | 26,770 |
Basic Shares | 66,521 | 66,521 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.74 |